Amarin Corp PLC (AMRN) オプション

In case you missed this.

https://ec.europa.eu/health/documents/community-register/2025/20250123165277/dec_165277_en.pdf

.

Expanding the triglyceride range in clinical trials: therapeutic opportunities
https://doi.org/10.1093/eurheartj/ehaf074
Published: 14 February 2025

No worries . Glad you are keeping track of the legal action .
Kiwi

New England Asset Management is a wholly-owned subsidiary of General Re, an insurance company owned by Berkshire Hathaway.

https://www.neamgroup.com/our-story

They filed a 13F-HR on Feb 14, which presents holdings as of Dec 31 2024. At that time, they owned Pfizer shares.

https://www.sec.gov/Archives/edgar/data/1004244/000108514625001696/xslForm13F_X02/infotable.xml

To determine whether they increased/decreased ownership, you'd need to look at the previous filing.

https://www.sec.gov/Archives/edgar/data/1004244/000108514624005429/xslForm13F_X02/infotable.xml

If you compare the two, you'll find that NEAM decreased their share holdings of Pfizer between Sep 30 and Dec 31. As these reports are just snapshots in time, there's no way of knowing how frequently they trade, nor what their current holdings are.

The two sec.gov links above don't give any indication as to which date they refer. To determine that, you need to click on the "Filing" box next to each 13F-HR listing at this link:

https://www.sec.gov/edgar/browse/?CIK=1004244

https://stocktwits.com/SanDiegoLiving/message/604328532

https://stocktwits.com/SanDiegoLiving/message/604463080

SK, I had not heard until I saw your post today.  Doing some very quick and abbreviated search I am coming up with mixed and contradictory stories, except for the following.  Apparently Berkshire bought New England Asset Management, and through that vehicle shares of PFE are being bought.  The two things I dislike is that the reporting takes 45 days before we find out what they are doing and then if they are heavily invested then you have to worry that they dump it.  But I will take all that if we can get Buffett involved and others will follow. 

Thanks

Kiwi, Thanks.
Sleven,

OT- rmb- have you seen the chatter about Berkshire buying pfe stock? I have been looking around to verify this morning. That beaten down company sure could use it.

Supreme Court dockets are updated at varying speeds depending on the type of filing and its review process:

Electronic Filings: Most subsequent filings in a case are updated on the docket within 10-15 minutes of submission through the electronic filing system, provided they do not require review by the Clerk’s Office.

Paper Filings: Documents submitted in paper form, such as certiorari petitions or case-initiating documents, are added to the docket only after being reviewed and accepted by the Clerk’s Office. This process can take several days, especially if the documents are mailed to the Court.

Emergency Applications: For urgent cases requiring immediate attention, such as stays of execution or procedural matters, filings may be expedited. However, these still require direct contact with the Clerk’s Office to ensure prompt action
.
Thus, while updates for routine electronic filings are quick, more complex or paper-based submissions depend on administrative review and may take longer.

Application (24A652) to extend the time to file a petition for a writ of certiorari from January 15, 2025 to February 14, 2025, submitted to The Chief Justice.
Kiwi

Lizzy, That is certainly possible. I have no idea how quickly the docket is updated.
Sleven,

sleven, maybe it was filed last minute yesterday so it's possible it will show up on Tues. since Monday is another holiday for govt workers.

RMB, I would be surprised if they simply missed the deadline. The docket is probably not updated. We will see.
Sleven,

I don't know enough about this kind of stuff, but when I saw your previous post with the link, I was wondering why you or no one else posted the Hikma filing. So it appears either they missed the deadline or I wonder if it is just possible that it hasn't been posted anywhere yet where the public can access it yet? Clerk in charge on a Valentine's Day date?

Did Hikma miss the deadline?
Sleven,

https://www.supremecourt.gov/docket/docketfiles/html/public/24A652.html
Sleven,

FFS. just to clarify ...you have no position , neither long or short ..?
Kiwi

DMC, because Morgan Stanley is a prime broker it may not be specifically for their own account but for other funds managers who use Morgan Stanley as their prime broker. Pls see below explanation.

When a brokerage firm files a Form 13F, it is reporting the holdings of its own accounts as well as any accounts for which it exercises investment discretion and has assets under management of $100 million or more. This includes accounts for which the firm acts as an investment adviser or has discretionary authority.

Wonder if Morgan Stanley looked st the chart before adding. 

It is an opinion (fundamentally) that is CONFIRMED by technical factors, making a high reward/low risk trade entry. Unlike an opinion, hope or gut feeling that conflicts with technical factors(unconfirmed) = the basis of Confirmation bias.

My reason for debating you on this topic is your incessant opinion that all price action is fundamentally driven. It is not. There are unique instances when price action is driven by both, hence my quote
When the fundamentals suggest a trade and technical factors confirm that signal, you have a very powerful combination. That combination is the most optimal way to win in the market. However, when only one and not the other present, you simply have a contra-trend trade - which in the case of AMRN - likely burns out (reverses) when trendline resistance is encountered. Contra-trend trades can produce profits, but only if TA is used to govern entry/exit and risk management.

There is no point in continuing this back and forth ... I'm no longer willing to play Ring Around the Rosie with you.

P.S. Here are a few more of yours that should help end the debate.
4/25/2023
FFS. thx. re
From a TA perspective the outlook is bleak; a fresh Death Cross on the heels of a failed upthrust of the down sloping 200MA and a weak MACD that is rolling over (Impulse has turned red). Down volume is expanding as the last 2 days have printed 2 of possibly 3 black Crow candles (very bearish).

If we aren't higher then today .... 30-90 days from now.... I'll be happy to say you were right .
I think its very hard if not impossible to pick exact bottoms ...so we'll see
And this post when you mocked all those posters who turned bearish on the PPS
6/3/2023
A new list for AMRN board readers .
Years ago I posted about keeping a list of all the over the top AMRN bulls . In reality I only kept track of the positions of JL and Raf ...so sorry to disappoint all of you who thought you were being tracked .
Now I'm starting a list of all those who are so bearish on AMRN ...feel free to add yourself to this list if you feel AMRN is likely to test $1
So far I have FFS , John ( the one in Canada ) BBI ( expects AMRN to drift down to its annual low ) , johnhanque and seve...sound pretty negative ,goldenflyer ( its a losing proposition buying this stock )

So to start ..those bearish on AMRN at recent levels
FFS,
John
BBI
Johnanque and Seve
Golden flyer
Free free to add yourself to the list if you share the views of those listed above

For a dude with multiple names and over 21,675 posts like the above ... it makes me wonder why you litter on this board, yet haven't bought or sold the stock for 9 months? Why is that? I wouldn't bother asking if you actually contributed helpful/useful information relative to the stock price of AMRN.

Morgan Stanley added.
https://fintel.io/so/us/amrn/morgan-stanley

https://stocktwits.com/CostanzaGeorge/message/604414218

FFS. isn't this an opinion When the fundamentals suggest a trade and technical factors confirm that signal, you have a very powerful combination.
A quote from your post .
By the way I agree with the approach of fundamentals suggesting a trade and technical factors confirming that signal .
I agree I have a bias re AMRN . I take the drug Vascepa / IPE ...but stop loss's have always preventing me from riding this or any position all the way down.

So where are you now ...does the 200 day MA need to be taken out to the upside , on a high volume day for U to go long ?
I haven't had a position in AMRN since the CFO left ...months ago
Kiwi
PS. And if you're going to comb thru my IHUB posts ...at least include those on APP and SWAV. :--)

That is my point with you. You base everything on "Conditional Opinion"..
How can you safely invest/trade on conditional opinion? You were long AMRN based on conditional opinion. Because of your FOMO induced conformational bias (that you ironically blame everyone for), you were willing to multiply your mistake 5 times!

Actually I might 5X my position ....see how I feel tomorrow .
Buying at $1.19
Not suggesting anyone do like wise.
Do your own DD and know your risk tolerance .

Reasons for buying
Seems very undervalued based on cash on hand and total inventory .
A bet that Denner will find a way to at least get the PPS up to his breakeven price

The stock price turned against you and proceeded to plunge to a low of .65/ share.

True fundamental investing does not include the words opinion, feel, seems, or bet. Fundamental investing is the process of gaming probabilities of future gains through a mix of current, past and projected metrics; P/S, P/E, EPS, etc.. In fact, O'Shaughnessy in his book What Works on Wall Street developed his popular Cornerstone Growth Strategy that searched for stocks from the all stocks universe which:

• Have a capitalization of $150 million or more.
• Have earnings gains for five consecutive years.
• Have price-to-sales ratios below 1.5.
• Display the best one-year price performance in the all stocks group.

These stocks have been shown to have an optimal mix between growth and Sharpe ratio, providing some of the highest/safest returns in the market over time.

AMRN ranks poor in all those criteria, leaving you with only hope of an event and that's a "bet," not an investment.

Don't get me wrong, I use FA criteria, but only in this order:
The key principle is to use fundamental information as an idea generator and technical studies as a trigger. The technical can either release you to pursue that trade or stop you from going any further.
No matter how good a fundamental story, if the technical factors do not confirm it, there is no trade. This rule applies to both bullish and bearish fundamental information. When the fundamentals suggest a trade and technical factors confirm that signal, you have a very powerful combination.
--Sell & Sell Short

FFS. That opinion was conditional on ...but if sales pick up in the UK , keep market share in the US and they can control costs / use up long term inventory
Did we keep market share in the US since then ...if we did it was only by dropping the wholesale acquisition cost . Since that post Kaiser IIRC went generic and we lost another insurer

Wait ..I was wrong . We didn't lose market share ...we just lost our margins ( a fundamental event ) trying to maintain market share
Reports from late 2023 and throughout 2024 consistently indicate that Amarin retained over 50% of the market share in the U.S., with no significant loss in this metric during the period.
However, the company has faced challenges in the U.S. market due to declining net selling prices and margin erosion caused by generic competition, which has impacted revenues rather than market share

Kiwi

Happy Valentine's Day From CaptBeer!

The real crime of the century was your Uncle Joe gave Fauci a pardon. Fauci should be strung up like the rest of the phonies.

What fundamental event could trigger that ...hmm ? Kiwi the fundamental optimist. Are you feeling like this again...

6/3/2023, the PPS was 1.28/share
Yes moving the needle now .
Where is FFS when we need him ? It looks as tho we have broken above the very short term ( 1-3 mth ) down trend line . If this holds then those short , based on TA are likely to cover their short positions .
A week or so ago the debate seemed about how soon we would test $1 .
We may now be able to break the lower lows trend at least ...so instead of the needle moving lower we may be now moving sideways to up .

I'm not predicting $5 or anything like it soon ....but if sales pick up in the UK , keep market share in the US and they can control costs / use up long term inventory ...then IMHO we have probably seen the bottom.

Sadly, the stock price did indeed descend below a 1.00, into the abyss... all the way down to .43/share - a level no one but one (who adhered to the TA message) expected.

Yep. agree ...needs to break thru the 200 day MA on increased vol .
What fundamental event could trigger that ...hmm ?
Kiwi

A bounce off its 50 day MA gets trumped by a falling 200 day MA or long term down trend.

We need a blowout volume

Yes. So far there is nothing to get excited about unless you are looking to short a pullup to falling resistance (ice line and 200 day moving average).



There is way too much overhead to blast through on less than average volume.

Its also bounced off its 50 day MA twice recently. Even FFS would probably think thats a good TA sign .
Kiwi

https://stocktwits.com/SanDiegoLiving/message/604328532

Well if your theory that the Naz will grant AMRN an extension, to comply with their listing requirements ...trade over $1 for 10 business days ....IF that happens , stock will definitely be higher .
Kiwi

I would do unthinkable things to have that average 🤣🤣

Capt, great visuals. Thx

bullrunner, for what it's worth the 200 day SMA is .6392. If it hits .64 and holds we could go higher. We need a blowout volume day to move much higher. Just sayin

BREAKING:
As reported earlier on ST by @CostanzaGeorge and @SanDiegoLiving:

The SmPC at the European Medicines Agency (EMA) has approved variations in the 2025 labeling Guidelines for VAZKEPA® by expanding the Mechanisms of Action (MOA) beyond TG reduction and finally putting to rest the Mineral Oil Placebo conspiracy!

I wish I had your average Bull. I'm still at $2.27 with 104k shares

I have 205k shares now ave .57. Also bringing my followers into amrn one by one.

Agreed Rose.....it would be fun to have a few drinks with some characters on this board after AMRN gets bought out by BP for a price that is great for all longs.

I also lived in Fort Pierce back in the day when I was "young and handsome"...... now I'm just "and"

Anticipating no change but Sarissa has not yet filed 13F due tomorrow. The second largest holder Kynam has also not filed and they added about 250k shares to take them to 12.4m in Q3.

Yep.  Port Orange/New Smyrna Beach. 
It would really be nice to discuss our old haunts if and when we could be celebrating the resurrection of our investment here in Amarin.  Last couple of days have reawakened our hopes here. 

Same here...... I was living in Melborne

Well maybe Denner needs to cover his short position ( didn't U post he was short ) ...and that would explain the decrease in stock short .
Of course theres something called fiduciary responsibility ...but maybe he's exempt.
Did U ever work out how much AMRN would have to spend out of cash on hand ...to buy back enough stock around 50c to get the PPS over $1 ...just wondering
Kiwi

RMB. if they were convinced thru confirmatory trials that the sub group mentioned by Capt ...very low HDL , high TG and LDL over 100 mg/dl ...my lipid profile ...actually saw something like at 42 % risk reduction ...NNT of 10 ...they IMHO would obviously cover V for at least this lipid profile . It would be a huge cost savings to the health provider.
Problem is that Germany equates Vazkepa with Ezetimbe ,,,which IIRC is about 6 -11 % risk reduction
Relative Risk Reduction: The IMPROVE-IT trial demonstrated that adding ezetimibe to statin therapy reduced major cardiovascular events by 6% to 11% relative to statins alone, including reductions in first and recurrent events such as myocardial infarction (MI), stroke, and revascularization23.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175792544

Problem is the powers that be on the German Health dept dont believe the RR cited by Capt .
And AMRN is doing nothing to change that
Kiwi

I agree if the reason for refusal to reimburse is because they don't have or don't want to spend the money to pay for V.  I disagree if the reason for their refusal to reimburse is because the evidence for V was questionable. 

RMB, I can only hope that they are waiting to make an announcement at their ER CC. 

If this change is as meaningful as some think, then it is certainly news-worthy.

It goes back to what I have often said. There must be a reason why Denner has explicitly chosen NOT to market Vascepa or the company. In the past 12 months, about the only marketing or PR I have seen were those items that are required by the SEC. 

Why others don't question his motives for the complete lack of marketing sort of boggles my mind. 

Thx ...my understanding is that its an EU authorization to market , prescribe Vazkepa in the EU .
It doesnt mean the various EU health depts are now going to more generously reimburse for it or in the case of Germany and France , even start reimbursing for it

Kiwi